Hill Ventures Sutter Net Worth
The estimated Net Worth of Hill Ventures Sutter is at least $23.3 Million dollars as of 2 July 2018. Hill Sutter owns over 134,735 units of Forty Seven stock worth over $23,280,040 and over the last 16 years Hill sold FTSV stock worth over $0.
Hill Sutter FTSV stock SEC Form 4 insider trading
Hill has made over 7 trades of the Forty Seven stock since 2006, according to the Form 4 filled with the SEC. Most recently Hill bought 134,735 units of FTSV stock worth $2,155,760 on 2 July 2018.
The largest trade Hill’s ever made was buying 791,347 units of Forty Seven stock on 30 March 2007 worth over $791,347. On average, Hill trades about 143,313 units every 211 days since 2004. As of 2 July 2018 Hill still owns at least 2,906,372 units of Forty Seven stock.
You can see the complete history of Hill Sutter stock trades at the bottom of the page.
What’s Hill Sutter’s mailing address?
Hill’s mailing address filed with the SEC is 755 PAGE MILL ROAD, SUITE A-200, , PALO ALTO, CA, 943041005.
Insider trading at Forty Seven
Over the last few years, insiders at Forty Seven have traded over $4,118,522 worth of Forty Seven stock and bought 2,621,245 units worth $41,666,515 . The most active insider traders include Tench Coxe, Michael L Speiser, and Jeffrey W Bird. On average, Forty Seven executives and independent directors trade stock every 7 days with the average trade being worth of $569,591. The most recent stock trade was executed by Mark Anthony Mc Camish on 20 May 2019, trading 16,500 units of FTSV stock currently worth $80,520.
What does Forty Seven do?
Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.
What does Forty Seven’s logo look like?
Complete history of Hill Sutter stock trades at Corcept Therapeutics, Pure Storage, Yext, Restoration Robotics, and Forty Seven
Forty Seven executives and stock owners
Forty Seven executives and other stock owners filed with the SEC include:
- Mark McCamish, President, Chief Executive Officer, Director
- Ann Rhoads, Chief Financial Officer
- Chris Takimoto, Chief Medical Officer
- Ian Clark, Independent Director
- Craig Gibbs, Chief Business Officer
- Kristine Ball, Independent Director
- Jeffrey Bird, Lead Independent Director
- Dennis Henner, Independent Director
- Ravindra Majeti, Independent Director
- Irving Weissman, Independent Director
- Samuel J Iii Pullara,
- Harbor Master Investors (Ca…, 10% owner
- Michael L Speiser, 10% owner
- Stefan A Dyckerhoff,
- Venture Partners X, L.P.Lig…,
- Hill Ventures Sutter,
- Peter Nieh, 10% owner
- Christopher J Schaepe, Director
- Tench Coxe, 10% owner
- Dennis Henner, Director
- James N White, 10% owner
- Venture Partners Select Ii,…,
- Ravi Mhatre, 10% owner